Ironwood Pharmaceuticals IRWD Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Ironwood Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's interest paid?
- Ironwood Pharmaceuticals (IRWD) reported interest paid of $7.58M in Q4 2025.
- How has Ironwood Pharmaceuticals's interest paid changed year-over-year?
- Ironwood Pharmaceuticals's interest paid decreased by 6.8% year-over-year, from $8.14M to $7.58M.
- What is the long-term trend for Ironwood Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's interest paid has grown at a 43.2% compound annual growth rate (CAGR), from $7.22M to $30.33M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.